Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Sabra Health Care REIT, Inc. ?
1
Poor long term growth as Operating profit has grown by an annual rate of 7.32%
2
The company has declared Positive results for the last 6 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 355.37 MM
- INTEREST COVERAGE RATIO(Q) Highest at 431.92
3
With ROE of 5.87%, it has a very attractive valuation with a 1.87 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 13.72%, its profits have risen by 14% ; the PEG ratio of the company is 3.9
- At the current price, the company has a high dividend yield of 526.3
4
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
5
Consistent Returns over the last 3 years
- Along with generating 13.72% returns in the last 1 year, the stock has outperformed S&P 500 in each of the last 3 annual periods
How much should you hold?
- Overall Portfolio exposure to Sabra Health Care REIT, Inc. should be less than 10%
- Overall Portfolio exposure to Realty should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Realty)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Sabra Health Care REIT, Inc. for you?
Low Risk, High Return
Absolute
Risk Adjusted
Volatility
Sabra Health Care REIT, Inc.
14.35%
1.97
20.41%
S&P 500
13.68%
0.71
19.28%
Quality key factors
Factor
Value
Sales Growth (5y)
5.57%
EBIT Growth (5y)
7.32%
EBIT to Interest (avg)
2.36
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
0.68%
Dividend Payout Ratio
188.56%
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
6.74%
ROE (avg)
3.04%
Valuation Key Factors 
Factor
Value
P/E Ratio
32
Industry P/E
Price to Book Value
1.87
EV to EBIT
19.55
EV to EBITDA
11.47
EV to Capital Employed
1.89
EV to Sales
6.71
PEG Ratio
3.92
Dividend Yield
526.26%
ROCE (Latest)
9.68%
ROE (Latest)
5.87%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Movement
5What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 355.37 MM
INTEREST COVERAGE RATIO(Q)
Highest at 431.92
-7What is not working for the Company
PRE-TAX PROFIT(Q)
At USD 29.99 MM has Fallen at -35.2%
NET PROFIT(Q)
At USD 29.53 MM has Fallen at -35.56%
RAW MATERIAL COST(Y)
Grown by 18.86% (YoY
Here's what is working for Sabra Health Care REIT, Inc.
Operating Cash Flow
Highest at USD 355.37 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Interest Coverage Ratio
Highest at 431.92
in the last five periodsMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Depreciation
Highest at USD 51.41 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for Sabra Health Care REIT, Inc.
Pre-Tax Profit
At USD 29.99 MM has Fallen at -35.2%
over average net sales of the previous four periods of USD 46.28 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD 29.53 MM has Fallen at -35.56%
over average net sales of the previous four periods of USD 45.83 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Raw Material Cost
Grown by 18.86% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






